The appropriate duration of anticoagulation for venous thromboembolism (VTE) in patients who have a transient provoking factor (e.g., surgery, trauma, or immobility) and concomitant enduring risk ...
In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and ...
The Eliquis 360 Support program offers a 40% discount on apixaban, targeting uninsured or underinsured patients to improve access and affordability. Apixaban is the most prescribed oral anticoagulant ...
In the study, which entered people with both AF and recent acute coronary syndromes (ACS) or percutaneous coronary intervention (PCI), all of whom went on a P2Y12 inhibitor, such as clopidogrel, the ...
If you’re experiencing severe side effects from the blood thinner warfarin, a doctor may recommend an alternative known as non-vitamin K oral anticoagulants (NOACs). Non-vitamin K oral anticoagulants ...
MADRID, Spain—For patients who experience venous thromboembolism (VTE) provoked by surgery, immobility, or other factors and who face ongoing risk factors, 12 months of low-intensity apixaban (Eliquis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results